Vosevi Interactions
There are 237 drugs known to interact with Vosevi (sofosbuvir/velpatasvir/voxilaprevir), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 52 are major, 178 are moderate, and 7 are minor.
- View all 237 medications that may interact with Vosevi
- View Vosevi alcohol/food interactions (1)
- View Vosevi disease interactions (4)
Most frequently checked interactions
View interaction reports for Vosevi (sofosbuvir / velpatasvir / voxilaprevir) and the medicines listed below.
- Advate (antihemophilic factor)
- Daklinza (daclatasvir)
- Dupixent (dupilumab)
- Enbrel (etanercept)
- Entyvio (vedolizumab)
- Epclusa (sofosbuvir / velpatasvir)
- Esbriet (pirfenidone)
- Gleevec (imatinib)
- Harvoni (ledipasvir / sofosbuvir)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Mavyret (glecaprevir / pibrentasvir)
- Moderiba (ribavirin)
- NovoSeven RT (coagulation factor viia)
- Ofev (nintedanib)
- omeprazole
- Opdivo (nivolumab)
- Placidyl (ethchlorvynol)
- Procysbi (cysteamine)
- Prograf (tacrolimus)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Repatha (evolocumab)
- Revlimid (lenalidomide)
- ribavirin
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecfidera (dimethyl fumarate)
- Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
Vosevi alcohol/food interactions
There is 1 alcohol/food interaction with Vosevi (sofosbuvir / velpatasvir / voxilaprevir).
Vosevi disease interactions
There are 4 disease interactions with Vosevi (sofosbuvir / velpatasvir / voxilaprevir) which include:
Report options
More about Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
- Vosevi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Mavyret
Mavyret is used to treat adults and children 3 years of age and older with acute or chronic ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Zepatier
Zepatier (elbasvir and grazoprevir) is used to treat chronic hepatitis C. Includes Zepatier side ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
